Literature DB >> 29173517

Complementary and Alternative Medicine Strategies for Therapeutic Gut Microbiota Modulation in Inflammatory Bowel Disease and their Next-Generation Approaches.

Abigail R Basson1, Minh Lam1, Fabio Cominelli2.   

Abstract

The human gut microbiome exerts a major impact on human health and disease, and therapeutic gut microbiota modulation is now a well-advocated strategy in the management of many diseases, including inflammatory bowel disease (IBD). Scientific and clinical evidence in support of complementary and alternative medicine, in targeting intestinal dysbiosis among patients with IBD, or other disorders, has increased dramatically over the past years. Delivery of "artificial" stool replacements for fecal microbiota transplantation (FMT) could provide an effective, safer alternative to that of human donor stool. Nevertheless, optimum timing of FMT administration in IBD remains unexplored, and future investigations are essential.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Complementary and alternative medicine; Crohn disease; Gut microbiota; Inflammatory bowel disease; Next-generation; Nutraceuticals; Ulcerative colitis

Mesh:

Substances:

Year:  2017        PMID: 29173517      PMCID: PMC5909826          DOI: 10.1016/j.gtc.2017.08.002

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  396 in total

1.  European regulations on nutraceuticals, dietary supplements and functional foods: a framework based on safety.

Authors:  Patrick Coppens; Miguel Fernandes da Silva; Simon Pettman
Journal:  Toxicology       Date:  2006-02-15       Impact factor: 4.221

2.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells.

Authors:  Yukihiro Furusawa; Yuuki Obata; Shinji Fukuda; Takaho A Endo; Gaku Nakato; Daisuke Takahashi; Yumiko Nakanishi; Chikako Uetake; Keiko Kato; Tamotsu Kato; Masumi Takahashi; Noriko N Fukuda; Shinnosuke Murakami; Eiji Miyauchi; Shingo Hino; Koji Atarashi; Satoshi Onawa; Yumiko Fujimura; Trevor Lockett; Julie M Clarke; David L Topping; Masaru Tomita; Shohei Hori; Osamu Ohara; Tatsuya Morita; Haruhiko Koseki; Jun Kikuchi; Kenya Honda; Koji Hase; Hiroshi Ohno
Journal:  Nature       Date:  2013-11-13       Impact factor: 49.962

3.  Oral delivery of glutamic acid decarboxylase (GAD)-65 and IL10 by Lactococcus lactis reverses diabetes in recent-onset NOD mice.

Authors:  Sofie Robert; Conny Gysemans; Tatiana Takiishi; Hannelie Korf; Isabella Spagnuolo; Guido Sebastiani; Karolien Van Huynegem; Lothar Steidler; Silvia Caluwaerts; Pieter Demetter; Clive H Wasserfall; Mark A Atkinson; Francesco Dotta; Pieter Rottiers; Tom L Van Belle; Chantal Mathieu
Journal:  Diabetes       Date:  2014-03-27       Impact factor: 9.461

4.  Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P.

Authors:  F Guagnini; M Valenti; S Mukenge; I Matias; A Bianchetti; S Di Palo; G Ferla; V Di Marzo; T Croci
Journal:  Gut       Date:  2006-01-19       Impact factor: 23.059

5.  Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors.

Authors:  Christel Rousseaux; Xavier Thuru; Agathe Gelot; Nicolas Barnich; Christel Neut; Laurent Dubuquoy; Caroline Dubuquoy; Emilie Merour; Karen Geboes; Mathias Chamaillard; Arthur Ouwehand; Greg Leyer; Didier Carcano; Jean-Frédéric Colombel; Denis Ardid; Pierre Desreumaux
Journal:  Nat Med       Date:  2006-12-10       Impact factor: 53.440

Review 6.  Fecal microbiota transplantation in inflammatory bowel disease: the quest for the holy grail.

Authors:  B Pigneur; H Sokol
Journal:  Mucosal Immunol       Date:  2016-07-27       Impact factor: 7.313

7.  Bacteriophages support anti-tumor response initiated by DC-based vaccine against murine transplantable colon carcinoma.

Authors:  Elzbieta Pajtasz-Piasecka; Joanna Rossowska; Danuta Duś; Beata Weber-Dabrowska; Agnieszka Zabłocka; Andrzej Górski
Journal:  Immunol Lett       Date:  2007-12-03       Impact factor: 3.685

8.  Linking long-term dietary patterns with gut microbial enterotypes.

Authors:  Gary D Wu; Jun Chen; Christian Hoffmann; Kyle Bittinger; Ying-Yu Chen; Sue A Keilbaugh; Meenakshi Bewtra; Dan Knights; William A Walters; Rob Knight; Rohini Sinha; Erin Gilroy; Kernika Gupta; Robert Baldassano; Lisa Nessel; Hongzhe Li; Frederic D Bushman; James D Lewis
Journal:  Science       Date:  2011-09-01       Impact factor: 47.728

9.  (R,S)-tetrahydropapaveroline production by stepwise fermentation using engineered Escherichia coli.

Authors:  Akira Nakagawa; Chiaki Matsuzaki; Eitaro Matsumura; Takashi Koyanagi; Takane Katayama; Kenji Yamamoto; Fumihiko Sato; Hidehiko Kumagai; Hiromichi Minami
Journal:  Sci Rep       Date:  2014-10-21       Impact factor: 4.379

10.  Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials.

Authors:  David Bikard; Chad W Euler; Wenyan Jiang; Philip M Nussenzweig; Gregory W Goldberg; Xavier Duportet; Vincent A Fischetti; Luciano A Marraffini
Journal:  Nat Biotechnol       Date:  2014-10-05       Impact factor: 54.908

View more
  10 in total

1.  A Probiotic for Ulcerative Colitis: The Culture Wars Continue.

Authors:  Bincy P Abraham; Eamonn M M Quigley
Journal:  Dig Dis Sci       Date:  2018-07       Impact factor: 3.199

Review 2.  Therapeutic effect of methane and its mechanism in disease treatment.

Authors:  Zhou-Heng Ye; Ke Ning; Bradley P Ander; Xue-Jun Sun
Journal:  J Zhejiang Univ Sci B       Date:  2020 Aug.       Impact factor: 3.066

3.  'Cyclical Bias' in Microbiome Research Revealed by A Portable Germ-Free Housing System Using Nested Isolation.

Authors:  Alexander Rodriguez-Palacios; Natalia Aladyshkina; Jessica C Ezeji; Hailey L Erkkila; Mathew Conger; John Ward; Joshua Webster; Fabio Cominelli
Journal:  Sci Rep       Date:  2018-02-28       Impact factor: 4.379

4.  Selective Targeting of Tumour Necrosis Factor Receptor 1 Induces Stable Protection from Crohn's-Like Ileitis in TNFΔARE Mice.

Authors:  Rajrupa Chakraborty; Mia R Maltz; Diana Del Castillo; Purvi N Tandel; Nathalie Messih; Martha Anguiano; David D Lo
Journal:  J Crohns Colitis       Date:  2022-07-14       Impact factor: 10.020

5.  The Interplay Between Use of Biological Therapies, Psychological State, and the Microbiome in IBD.

Authors:  Paris Tavakoli; Ute Vollmer-Conna; Dusan Hadzi-Pavlovic; Xabier Vázquez-Campos; Michael Carl Grimm
Journal:  Front Med (Lausanne)       Date:  2022-07-19

Review 6.  Regulation of the intestinal microbiota: An emerging therapeutic strategy for inflammatory bowel disease.

Authors:  Bei Yue; Zhi-Lun Yu; Cheng Lv; Xiao-Long Geng; Zheng-Tao Wang; Wei Dou
Journal:  World J Gastroenterol       Date:  2020-08-14       Impact factor: 5.742

Review 7.  Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases.

Authors:  Melanie Kienzl; Martin Storr; Rudolf Schicho
Journal:  Clin Transl Gastroenterol       Date:  2020-01       Impact factor: 4.396

Review 8.  Microphysiological Engineering of Immune Responses in Intestinal Inflammation.

Authors:  Yoko M Ambrosini; Woojung Shin; Soyoun Min; Hyun Jung Kim
Journal:  Immune Netw       Date:  2020-04-08       Impact factor: 6.303

9.  Deficiency of Dietary Fiber in Slc5a8-Null Mice Promotes Bacterial Dysbiosis and Alters Colonic Epithelial Transcriptome towards Proinflammatory Milieu.

Authors:  Sathish Sivaprakasam; Pramodh K Ganapathy; Mohd Omar Faruk Sikder; Moamen Elmassry; Sabarish Ramachandran; Kameswara Rao Kottapalli; Vadivel Ganapathy
Journal:  Can J Gastroenterol Hepatol       Date:  2019-12-27

Review 10.  Limosilactobacillus fermentum CECT5716: Mechanisms and Therapeutic Insights.

Authors:  María Jesús Rodríguez-Sojo; Antonio Jesús Ruiz-Malagón; María Elena Rodríguez-Cabezas; Julio Gálvez; Alba Rodríguez-Nogales
Journal:  Nutrients       Date:  2021-03-21       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.